Stroke Management

Maintaining high standards of Treatment, Patient Safety and Auditable Patient Recording is a constant issue for all healthcare providers, Stroke Units and Cardiology Departments. It is well documented that time is crucial when it comes to treating Strokes, the recommended treatment is using a ‘clot-busting’ medicine such as alteplase, which dissolves Blood clots (thrombolysis). However, alteplase is only effective if started during the first few hours after the onset of the Stroke. After that time, the medicine has not been shown to have beneficial effects. Even within this narrow time frame, the quicker alteplase can be started the better the chance of recovery. However, not all Patients are suitable for thrombolysis treatment.

Stroke360 can speed up the decision making process through improved and quicker information sharing.

NICE (National Institute for Health and Care Excellence)

Guidance States:

Alteplase is recommended within its marketing authorisation for treating acute ischaemic Stroke in adults if:

• Treatment is started as early as possible within 4.5 hours of onset of Stroke symptoms• Intracranial haemorrhage has been excluded by appropriate imaging techniques